Test Price
850 AED✅ Home Collection Available
HLA‑Cw6 (C*06) Typing Test in UAE | 850 AED | 2026 DHA Guidelines
تحليل HLA‑Cw6 (C*06) في الإمارات | 850 درهم | معتمد من هيئة الصحة بدبي
Clinical Precision, UAE‑Wide Convenience
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑accredited Reverse SSOP‑Luminex processing, verified against 2026 AI‑curated datasets.
- Premium Logistics: Paid Hospital‑Grade Home Collection with ISO‑compliant cold‑chain transport (8 AM–11 PM) and VIP Mobile Phlebotomy.
- Clinical Guidance: Complimentary telephonic post‑test result interpretation with a DHA‑licensed immunogenetics specialist.
- Insurance: Direct Billing Verification — send your Emirates ID and policy card via WhatsApp +971 54 548 8731.
مختبرنا المعتمد وفق ISO 9001:2015 يقدم دقة تشخيصية 99.9% مع خدمة السحب المنزلي المدفوعة والتوجيه السريري عن بُعد في دولة الإمارات.
Test Overview
The HLA‑Cw6 (C*06) test is a high‑resolution genetic typing that identifies the specific immune‑related allele strongly linked to psoriasis, psoriatic arthritis, and certain inflammatory bowel conditions. في الإمارات، يُستخدم تحليل HLA‑Cw6 لدعم أطباء الروماتيزم والجلدية والجهاز الهضمي في توجيه خطط العلاج المناعي البيولوجي.
This test empowers patients and physicians by revealing genetic susceptibility, helping to personalise biologic therapy and predict disease progression under DHA‑endorsed protocols.
| Feature | Our Service (HLA‑Cw6 Typing) | Closest Alternative |
|---|---|---|
| Methodology | Reverse SSOP‑Luminex, high‑resolution C*06 allele discrimination | Generic HLA‑C low/intermediate resolution (SSP/SBT), often misses sub‑alleles |
| Clinical Relevance | Directly informs psoriasis/PsA/IBD biologic selection & risk stratification | Limited relevance; may require reflex testing |
| Turnaround Time | 10–12 working days | Often 14–21 days |
| Sample & Logistics | 4 mL whole blood (EDTA/acd tube), refrigerated home pickup, no freeze | May require additional tubes, limited home collection |
| Regulatory Compliance | UAE Federal Decree‑Law No. 41/2024, CDS 2026 (Minors), PDPL; ISO 9001:2015 (Cert INT/EGQ/2509DA/3139) | Variable; often not fully localised |
Physician Insight & Safety Protocol
“As a clinician deeply familiar with the UAE’s diverse population, I remind every patient that an HLA‑Cw6 positive result is a hereditary clue — not a diagnosis. It must be correlated with your full clinical picture and markers of inflammation. Think of it as a roadmap, not the destination.”
— Dr. PRABHAKAR REDDY, DHA License No. 61713011, Consultant Immunopathologist
⚠️ Clinical Notice: Do not discontinue any prescribed medication (including biologics, corticosteroids, or immunosuppressants) without explicit instruction from your treating physician.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Active skin infection at venipuncture site, known severe coagulopathy, inability to provide informed consent (including minors without guardian consent as per CDS Law 2026).
- Do NOT undergo home collection if: you are experiencing high fever, pustular skin eruption with systemic illness, or suspected transfusion reaction.
- Seek immediate ER care if: you develop sudden severe joint swelling, angina, or widespread pustular psoriasis after sample collection — these are unrelated to the test but require urgent attention.
- Always inform the phlebotomist of any bleeding disorders or anticoagulant use.
Patient FAQ & Clinical Guidance
Q: What exactly does a positive HLA‑Cw6 test mean for my health?
A positive result indicates an increased genetic predisposition to immune-mediated conditions like psoriasis and psoriatic arthritis, but it is not inevitable. Your doctor will combine this finding with your symptoms, joint examination, and inflammatory blood markers to assess your actual risk and tailor a precision prevention or treatment plan. In the UAE, this is a cornerstone of proactive biologic therapy selection.
س: ماذا تعني نتيجة HLA‑Cw6 الإيجابية لصحتي؟
الإجابة: أن تكون النتيجة إيجابية تعني وجود استعداد وراثي مرتفع لحالات مثل الصدفية والتهاب المفاصل الصدفي، لكن هذا لا يعني حتمية الإصابة. يجمع طبيبك هذه النتيجة مع الأعراض السريرية وعلامات الالتهاب لتقدير المخاطر الفعلية ووضع خطة علاجية دقيقة.
Q: Do I need to fast or stop my medications before giving a sample?
No fasting or medication adjustment is necessary; the test requires only a standard blood draw from your arm. Continue all prescribed treatments exactly as directed. Our DHA‑certified phlebotomist will collect 3–4 mL of blood in a lavender or yellow‑top tube, which is kept refrigerated during transport. There is absolutely no need to stop anti‑inflammatory drugs or biologics.
س: هل أحتاج إلى الصيام أو إيقاف الأدوية قبل سحب العينة؟
الإجابة: لا داعي للصيام أو تعديل أي دواء؛ التحليل يعتمد على عينة دم وريدية بسيطة. يستمر جميع العلاجات الموصوفة كما هي، ويتم جمع ٣-٤ مل في أنبوب خاص مع النقل المبرد حتى المختبر.
Q: How reliable is this for guiding my biologic therapy?
With 99.9% diagnostic sensitivity and Luminex‑based allele discrimination, our HLA‑Cw6 typing provides the highest clinical utility for predicting biologic response. In inflammatory arthritis and psoriasis, C*06 positivity often heralds better outcomes with IL‑17 or IL‑23 inhibitors. Your rheumatologist or dermatologist can use this result, alongside the latest DHA guidelines, to de‑escalate ineffective therapies and accelerate access to targeted treatment.
س: ما مدى موثوقية هذا التحليل لتوجيه علاجي البيولوجي؟
الإجابة: بدقة تشخيصية 99.9% وتقنية Luminex، يوفر تصنيف الأليل C*06 أعلى فائدة سريرية لتوقع استجابة العلاج البيولوجي. غالباً ما يرتبط إيجابية C*06 بنتائج أفضل مع مثبطات IL‑17 أو IL‑23، مما يساعد طبيبك في اتخاذ قرار علاجي دقيق وفق إرشادات هيئة الصحة بدبي.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians